- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03450148
Aversive Therapy for Smoking Cessation
Acceptability and Feasibility of Self Administered Aversive Therapy for Smoking Cessation
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The participants will be evaluated after 1 week and assessed for their ongoing participation and commitment to the study. Those still interested and eligible will be randomized to two groups described below and will continue the study for 3 more weeks. There will be follow up surveys at various time points while wearing the wristband (1 week, 2 week, 3 weeks) and a final survey at T=3 months.
The intervention group will continue to wear the wristband and the wristband will deliver a slight electric stimulus every time it is pressed.
The placebo group will wear continue to press the button on the wristband but it will not give a slight electric stimulus when pressed. Both groups will wear the device for a total of 4 weeks.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35294
- Univeristy of Alabama at Birmingham
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Current smoker (defined by the Center for Disease Control as an "adult who has smoked 100 cigarettes in his or her lifetime and who currently smokes cigarettes ". This will be determined based on participant baseline survey.
- Interested in quitting (contemplation stage and beyond, as defined by serious consideration of quitting smoking in the next 30 days
- Subject is equal to or greater than 19 years old
- Considers themselves "tech savvy" (based on self reported 5 point likert scale)
- Must have a smart phone with blue tooth capabilities
- Willing to receive aversive therapy if assigned to this group.
Exclusion Criteria:
- Anyone with a diagnosed arrhythmia or with a pacemaker or with a phobia or history of psychosis.
- Non-English speaking caregivers
- Lives outside of contiguous United States
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Pavlok wristband with electric stimulus
Participants in intervention group will wear wristband and will get a slight electric stimulus when they press the device
|
it is a device for various behavior modifications in the form of wristband which participants will wear on the wrist.
Device has maximum voltage of 0-500 volts, delivers a electric stimulus for a maximum of 1 sec and average duration of 0.2 secs
|
Placebo Comparator: Pavlok wristband without electric stimulus
Participants in control group will wear wristband and will not get a slight electric stimulus when they press the device
|
it is a device for various behavior modifications in the form of wristband which participants will wear on the wrist.
Participants will not receive any electric stimulus since this feature will be turned off.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Participants acceptability: short customized survey
Time Frame: T=0 to 3 months
|
Participants' acceptability/satisfaction will be assessed using a short customized survey.
The survey will include 8 questions with options ranging from strongly agree to strongly disagree for five questions and ranging from satisfaction to dissatisfaction for the remainder 3 questions.
Each question will be evaluated individually.
|
T=0 to 3 months
|
Evaluate the dropout among participants
Time Frame: T=0 to 3 months
|
Number of participants dropped out from time of randomization.
Dropout is defined as missing two follow up assessments.
|
T=0 to 3 months
|
Enrollment percentage of eligible participants
Time Frame: Baseline to T=0
|
PI will evaluate the percentage of participants that were enrolled after the 1 week run in period.
|
Baseline to T=0
|
Percentage of time wristband worn by participants
Time Frame: T=0 to one week
|
PI will evaluate the percentage of time the wristband is worn.
Instructions will be given to wear the wristband all of the waking hours.
|
T=0 to one week
|
Percentage of time wristband worn by participants
Time Frame: from one week to two weeks
|
PI will evaluate the percentage of time the wristband is worn.
Instructions will be given to wear the wristband all of the waking hours.
|
from one week to two weeks
|
Percentage of time wristband worn by participants
Time Frame: from two week to three weeks
|
PI will evaluate the percentage of time the wristband is worn.
Instructions will be given to wear the wristband all of the waking hours.
|
from two week to three weeks
|
Participants satisfaction: short customized survey
Time Frame: T=0 to 3 months
|
Participants' acceptability/satisfaction will be assessed using a short customized survey.
The survey will be a Likert scale and will include 2 questions with options ranging from satisfied to dissatisfied (with 1 indicating satisfaction and 5 indicating dissatisfaction).
One other question is a likert scale with options ranging from 1-3 with 1 indicating the device was very useful and 3 indicating the device was not at all useful.
A higher score indicates a worse outcome (less satisfaction with the device).
Each question will be evaluated individually.
|
T=0 to 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of participants that made a quit attempt
Time Frame: From T=0 to one week
|
PI will evaluate the percentage of participants that made a quit attempt as defined by absence of smoking for more than 24 hours in the previous seven days.
This will be assessed through the follow up survey given at various intervals.
|
From T=0 to one week
|
Percentage of participants that made a quit attempt
Time Frame: From T=1 week to 2 weeks
|
PI will evaluate the percentage of participants that made a quit attempt as defined by absence of smoking for more than 24 hours in the previous seven days.
This will be assessed through the follow up survey given at various intervals.
|
From T=1 week to 2 weeks
|
Percentage of participants that made a quit attempt
Time Frame: From T= 2 weeks to 3 weeks
|
PI will evaluate the percentage of participants that made a quit attempt as defined by absence of smoking for more than 24 hours in the previous seven days.
This will be assessed through the follow up survey given at various intervals.
|
From T= 2 weeks to 3 weeks
|
Average Degree of smoking reduction
Time Frame: From baseline to 3 months
|
PI will evaluate the average percentage of smoking reduction.
This will be quantified by the average number of cigarettes smoked at baseline compared to the average number of cigarettes smoked at 3 months.
This will be assessed via the "Follow survey".
|
From baseline to 3 months
|
Percentage of participants who had cessation of smoking.
Time Frame: T=0 to T= 3 weeks
|
P will evaluate the percentage of participants who had cessation of smoking, as defined by the absence of smoking in the previous 30 days.
This will be evaluated by the "Three month Questionnaire"
|
T=0 to T= 3 weeks
|
Before and after smoking self-efficacy score
Time Frame: Baseline to 3 months
|
The PI will evaluate the self-efficacy of the participant as evaluated by the "Baseline Smoking self-efficacy scale Short form".
There are 9 questions which will assess the confidence of the participant to not smoke.The investigators will use Likert scale for each question which assesses the participants confidence to "not smoke" in various circumstances.
The answers range from 1 to 5 with 1 indicating "not at all confident" and 5 indicating "extremely confident".
The overall score for each participant will be calculated by sum of scores from all items.
This score for individual subscales will be calculated by sum item scores so that the total score will range from 9 to 45, with a lower score indicating a worse outcome i.e. less confidence to not smoke).
|
Baseline to 3 months
|
Stage of change
Time Frame: From baseline until 3 months
|
The investigators will use Likert scale for each question to evaluate the motivation to change.
A score of 1 indicates that the participant has no intention to quit smoking and the score of 5 indicates that the participant is highly motivated.
Evaluate the initial stage of change of the participant as judged by "Screening Questionnaire, Stage of Change".
There is only 1 question.
|
From baseline until 3 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Laura Rochford, MD, University of Alabama at Birmingham
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- F23234543
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking Cessation
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
Nabi BiopharmaceuticalsNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco CessationUnited States
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Heidelberg UniversityPfizerTerminatedSmoking | Smoking Cessation | Tobacco Use CessationGermany
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
University of MiamiFlorida Department of HealthRecruitingSmoking Cessation | Tobacco Smoking | Tobacco Use CessationUnited States
-
The University of Hong KongNot yet recruitingSmoking Cessation Counseling Ability | Smoking Cessation Counseling PracticeHong Kong
-
University of VermontMayo Clinic; Alaska Native Tribal Health ConsortiumTerminatedSmoking | Smoking CessationUnited States
-
University of Wisconsin, MadisonCentiment LLCCompletedSmoking | Smoking CessationUnited States
-
Yale UniversityCompletedSmoking | Smoking CessationUnited States
Clinical Trials on Pavlok wristband with electric stimulus
-
Pôle Saint HélierINSA RennesCompleted
-
Pôle Saint HélierINSA RennesCompletedNeurological DisorderFrance
-
Pôle Saint HélierCompletedNeurological DisordersFrance
-
University of OklahomaWithdrawnRisk Reduction Behavior
-
Tel-Aviv Sourasky Medical CenterWithdrawn
-
Chi-Ming HuangUMKC School of MedicineNot yet recruitingConcussion | Head Injury Trauma
-
Virginia Polytechnic Institute and State UniversityRecruitingFood Preferences | Appetitive BehaviorUnited States
-
Harvard School of Dental MedicineNot yet recruitingDiabetes Mellitus | Periodontal Diseases
-
Uşak UniversityCompletedAnxiety | Preoperative Anxiety | Pediatric SurgeryTurkey